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ABSTRACT 
Retroviruses are enveloped viruses that use reverse transcriptase to convert their RNA genome 
into DNA which is integrated into the host DNA. They enter into the cell by a membrane fusion 
process. In this the viral membrane fuses with that of the cell so that the internal capsid of the 
virus with the genome can be released into the cell cytoplasm. The fusion is mediated by the 
spike protein in the viral membrane. In my thesis work I have studied how the spike proteins of 
two retroviruses, the human immunodeficiency virus typ 1 (HIV-1) and a murine leukemia virus 
(MLV), are able to catalyze the fusion reaction. I found that defined changes in the spike 
structure mediated different steps in the fusion process. As the spikes constitute the major target 
for neutralizing antibodies against the virus the structures of the spikes and its natural 
intermediate forms should facilitate development of retroviral vaccines and drugs, which are so 
heavily needed in the case of HIV-1. 
The spike is made as a trimeric transmembrane protein in the infected cell and incorporated into 
virus by budding at the cell surface. The spike then guides the virus to an uninfected cell for 
virus entry by membrane fusion. These tasks put several demands on the spike function. A key 
event is its binding to a receptor molecule of the target cell. This triggers, or activates the spike 
for membrane fusion. However, the activation should not occur in the cell where the virus is 
produced. Therefore, premature activation is prevented by synthesis of the spike in a precursor 
form, unable to fuse. Proteolytic cleavage of the spike, before receptor binding, then creates a 
mature form of the spike, which can be activated by the receptor. I have studied the maturation 
process of the Moloney (Mo)-MLV spike. 
The Mo-MLV spike precursor matures by two proteolytic cleavages. The first one is by the 
furin enzyme of the producer cell and this forms the receptor binding peripheral subunit (SU) 
and the fusion active transmembrane subunit (TM) of the spike. The second cleavage is made by 
the viral protease and occurs in newly released virus. It separates a short peptide, called the R-
peptide, from the membrane internal cytoplasmic tail (CT) of TM. I have studied the R-peptide 
cleavage using biochemical techniques and found that the cleavages in the trimeric spike occur 
by positive cooperativity, i.e. the cleavage of one subunit facilitates the cleavages of the two 
other TM subunits in the spike. This helps the spike to reach full fusion activity soon after virus 
budding. The activation of the spike by the receptor involves dissociation of SU from TM so 
that the latter can fuse the viral and the cell membranes. I also found that the R-peptide 
interfered with this dissociation step by inhibiting isomerization of the intersubunit disulfide in 
the Mo-MLV spike, which normally occurs soon after receptor binding. 
Using HIV-1 I studied how the primary receptor CD4 activated the spike for binding to the 
coreceptor, a chemokinreceptor. In this case I used cryo-electron microscopy and image 
processing to determine the 3D structures of the native unliganded and the CD4 bound spike. 
The spikes were released from virus, with or without bound CD4, by solubilization with TX-
100 and isolated for EM analysis by density gradient centrifugation. I found that the native spike 
had an open cage-like structure, where the protomeric unit formed a common roof and a lobe, 
and a leg on the side. This structure was verified by the unique fitting of the earlier determined 
atomic structure of the core portion of the peripheral subunit. CD4 binding caused the roof part 
to lift up probably to enable coreceptor binding and to open the roof for the fusion activated 
TM.   
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1. INTRODUCTION 
Viruses are intracellular parasites using target cells for producing new virus particles 
able to spread and invade more cells. There are many types of viruses and they can be 
divided into two main groups, enveloped viruses that are surrounded by a lipid 
membrane and naked viruses containing an outer protein shell. My thesis covers two 
different retroviruses, Moloney murine leukemia virus (Mo-MLV) and Human 
Immunodeficiency Virus type 1 (HIV-1), belonging to the enveloped virus group. These 
enveloped viruses fuse, or merge, their viral lipid membrane with the cell membrane, as 
a first step towards infection. Through this process the viral core with the genome gains 
entrance into the cell cytoplasm. I have focused my investigations to how this fusion 
mechanism is controlled. 
 
1.1  RETROVIRUS CLASSIFICATION AND PATHOGENESIS. 
Retroviruses are divided into seven different genera (Table 1). The first three genera are 
classified as simple retrovirus and the four last ones are described as complex retrovirus. 
The simple retroviruses contain the viral genes gag, pol and env, encoding the minimal 
number of proteins needed for a retrovirus infection. The complex retroviruses encode 
several accessory proteins. 
 
Table 1. Retrovirus genera. 
Genus Example 
Alfaretrovirus Avian leucosis virus (ALV) 
Betaretrovirus Mouse mammory tumour virus (MMTV) 
Gammaretrovirus Murine leukemia virus (MLV) 
Deltaretrovirus Human T-cell leukemia virus (HTLV) 
Epsilonretroviruses Walley dermal sarcoma virus  
Lentivirus Human immunodeficiency virus (HIV) 
Spumaretrovirus Human foamy virus (HFV) 
 
 
MLV is a simple retrovirus and belongs to the gammaretrovirus genus. The MLV group 
is further divided into subgroups depending on their use of host cell receptor for entry 
(Table 2). Ecotropic MLV, like Mo-MLV, uses the cationic amino acid transporter 
MCAT-1 and can only infect mouse and rat cells (Albritton et al., 1989; Davey et al., 
1997). Amphotropic MLV can infect murine as well as none murine cells (also human 
cells) and uses the receptor PIT-2, a sodium dependent transporter of phosphate (Miller 
et al., 1994; van Zeijl et al., 1994). Xenotropic MLV was first isolated from mouse but 
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the tropism differed from eco- and amphotropic viruses in that it could not infect mouse 
cells. Surprisingly it could efficiently infect cells of others species such as human, rabbit 
and cat. The receptor used by Xenotropic MLV is called XPR1 and is a protein of 
unknown function. However homologous proteins in yeast (SYG1) and plant (PHO) 
have been associated to signal transduction, phosphate sensing and transport (Tailor et 
al., 1999; Yang et al., 1999). The last subgroup of MLV is called polytropic. This group 
of viruses also uses the XPR1 receptor for entry. Even though xenotropic and polytropic 
MLV uses the same receptor they have different tropism. This has been mapped to 
variation in the extracellular loops of the receptor (Kozak, 2010). It is interesting to note 
that all receptors identified for gamma retroviruses have several transmembrane 
segments and are all believed to work as transporters of cargo from the outside to the 
inside of the cell. The transport properties of these receptors are not believed to have a 
function as such during entry. The receptor is thought to function only as a binding site, 
activating the entry mechanism of the virus (Wang et al., 1994; Soll et al., 2010). 
 
Table 2. MLV subgroups. 
Virus Example 
Ecotropic MLV Moloney (Mo)-MLV and Friend (Fr)-MLV 
Amphotropic MLV 4070A MLV 
Polytropic MLV Mink cell focus-inducing MLV (MCF-MLV) 
Xenotropic MLV Xenotropic murine leukemia virus-related virus (XMRV) 
 
 
The pathogenesis of MLV have recently gained a lot of interest when a xenotropic 
murine leukemia virus-related virus (XMRV) was suggested to be associated with 
chronical fatigue syndrome (CFS) and prostate cancer (Urisman et al., 2006; Lombardi 
et al., 2009; Schlaberg et al., 2009; Lo et al., 2010). These proposals are still 
controversial. Many other laboratories have been unable to detect XMRV in either CFS 
or prostate cancer patients. These differences in results have been explained by 
geographic differences in the distribution of XMRV, false positive results when using 
sensitive PCR assays, contamination of virus particles either from mice or humans and 
difficulties regarding endogenous retroviruses and how this can cause false positive 
results in serum and cell cultures (Hohn et al., 2009; Aloia et al., 2010; Groom et al., 
2010; Hue et al., 2010; Oakes et al., 2010; Robinson et al., 2010; Switzer et al., 2010). 
Even though XMRV in human disease is under debate it has been shown that XMRV is 
a human pathogen and can infect and spread in human cell lines, especially in prostate 
carcinoma cells (Rodriguez and Goff, 2010; Stieler et al., 2010). With the knowledge 
that MLV can induce leukemia and lymphoma in mice, it is also possible that XMRV 
can cause disease in humans. In a mouse model for XMRV infection it has been shown 
that the virus can infect the spleen, blood and brain  i.e. a similar tissue selectivity as 
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previously described for ecotropic and amphotropic MLV (Chatis et al., 1983; Rosen et 
al., 1985; Evans and Morrey, 1987; Sakuma et al., 2011). Further research in this field 
will tell us if XMRV or any other MLV related viruses are the source of human disease. 
The second virus in focus in my thesis is the complex retrovirus HIV-1, belonging to 
the lentivirus genus. Lentiviruses are divided into five serogroups reflecting the host 
they are associated with (see Table 3). One common aspect of lentiviruses is that the 
host cells are CD4 positive T cells. Most lentivirus use CD4 as a primary receptor for 
entry, one exception is FIV using the CD134 receptor (de Parseval et al., 2004; 
Shimojima et al., 2004).  
 
 
 
 
 
 
 
 
To complete entry lentiviruses also need to interact with a seven transmembrane 
protein, a coreceptor. In most cases the coreceptor is either the chemokine receptor 
CCR5 or CXCR4, but other similar coreceptors have been identified (Deng et al., 1996; 
Feng et al., 1996; Shimizu et al., 2009). Since lentiviruses target cells of the immune 
system, the infection creates immune deficiency when the target cells start to die. In the 
case of HIV-1 infection, this stage is known as Acquired Immunodeficiency Syndrome 
(AIDS) and the patient has an increased risk of dying by secondary infections. It has 
been noted that only a few percent of the CD4 positive T-cells are actually infected and 
still most of the helper T-cells die. In a recent study this phenomenon was shown to be 
caused by abortive HIV-1 infection in nonepermissive CD4 T-cells. It was found that 
the nonepermissive T-cells contained partial HIV reverse transcripts. Further it was 
shown that the accumulation of these transcripts activated the innate antiviral response 
followed by cell death (Doitsh et al., 2010). In 2009, 33 million people were infected by 
HIV (WHO homepage) and there is a vast need for a definite prevention of the virus. 
Efficient HIV drugs exist today, but a downside with these is the immense costs 
associated with the treatment making it less available for underprivileged third world 
countries. Another down side of current treatments is the development of drug 
resistance. Consequently the drugs are only prolongers of life, not an absolute cure.  
Table 3. Lentivirus subgroups. 
Virus Examples 
Bovine Lentivirus Bovine immunodeficiency virus (BIV) 
Equine Lentivirus  Equine infectious anemia virus (EIAV) 
Feline Lentivirus  Feline immunodeficiency virus (FIV) 
Ovine/caprine Lentivirus Visna Virus 
Primate Lentivirus Human immunodeficiency virus type 1 (HIV-1) 
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1.2  RETROVIRUS PARTICLES AND THEIR LIFECYCLE. 
I will start by describing the simple retrovirus, MLV and its lifecycle. Thereafter 
differences compared with the complex retrovirus HIV-1 will be issued. MLV are 
spherical, lipid surrounded viruses with a size of about 100 nm in diameter. The viral 
genome consists of a diploid, single stranded positive sense RNA, and contains three 
main coding domains common to all retrovirus, gag, pol and env, encoding the Gag and 
Gag-Pol polyproteins and the Env protein. The Gag polyprotein contains the structural 
protein units for the capsid (CA), nucleocapsid (NC), p12 and the matrix protein (MA) 
providing shape and structure for the virus particle. The CA proteins create a core 
surrounding the viral genome, the NC protein bind to the viral RNA inside the core and 
the MA protein bind to the inner side of the viral membrane. Pol contains the protein 
units for the viral enzymes, reverse transcriptase (RT), integrase (IN) and the protease 
(PR) needed to complete the viral lifecycle. The Env proteins make up the glycoproteins 
located in the viral membrane needed for entry of the virus into the host cell. Env binds 
to a specific host cell receptor that triggers a fusion mechanism merging the viral 
membrane with the cellular membrane. The purpose is to release the viral capsid core 
with the genome in the cytoplasm to initiate an infection. First the viral RT converts the 
virus RNA into double stranded DNA. This creates a pre-integration complex (PIC) 
believed to consist of the retrovirus genome, RT, IN, CA and NC together with cellular 
proteins. Recently it was also shown that p12 is required for a functional PIC (Prizan-
Ravid et al., 2010). The PIC is then transported into the cell nucleus where the viral 
DNA becomes inserted into the host genome by a mechanism driven by the viral IN 
enzyme. The integrated form of the virus is known as the provirus. From this the 
cellular transcription machinery replicates new viral genomes, which are also used for 
synthesis of viral proteins. Env synthesis is initiated on free ribosomes and then 
cotranslationally inserted into the endoplasmic reticulum (ER). After trimerization into 
spikes, Env is transported through the secretory pathway to the plasma membrane. The 
Gag and Gag-Pol polyproteins are synthesized on free ribosomes in the cell cytoplasm. 
The Gag interacts with transcribed unspliced viral RNA which will initiate Gag 
oligomerisation. Subsequently a myristoylated site in MA is exposed and targets the 
complex to the plasma membrane. Here, further Gag oligomerization forms a lattice 
below the membrane driving budding, spike association and release of virus particles. 
To complete budding retroviruses use the cellular endosomal sorting complex required 
for transport (ESCRT). This contains more than 20 proteins and associated factors and 
is required for several membrane fission events in eukaryotic cells. During or soon after 
budding the viral PR cleaves the Gag and Gag-Pol polyproteins into their separate 
proteins. In addition, for MLV, a 16 amino acid long peptide (the R-peptide) is cleaved 
by the viral PR at the C-terminal end of Env, i.e. in the membrane internal endo-domain 
also called the cytoplasmic tail (CT) (Coffin et al., 1997; Hunter, 1997; Rosenberg and 
Jolicoeur, 1997; Swanstrom and Wills, 1997; Vogt, 1997).  
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The remaining accessory proteins have evolved to evade and counteract the host defense 
mechanisms. During recent years it has been shown that retroviral host cells contain 
antiviral restrictions factors targeting different stages of the retrovirus lifecycle. Three 
main restriction factors have been found until now; the APOBEC3G, the tetherin and 
the TRIM5α. The APOBEC3G protein incorporates into virus particles and induces 
lethal hypermutations of the retroviral genome. The tetherin protein prevents virus 
release by clamping budded virus particles to the plasma membrane. The TRIM5α 
protein binds to incoming cores during the initial stage of the infection, preventing 
release of the viral genome into the cell cytoplasm. It has been shown that two HIV-1 
accessory proteins directly target these innate restriction factors. Vif binds to 
ABOBEC3G targeting it for degradation and thereby prevents it from being 
incorporated into viral particles. Vpu counteracts tetherin and thereby allows efficient 
virus release from the infected cell. Vpu has also been shown to down regulate CD4 to 
escape the immunsystem and avoid superinefection. Nef enhances viral replication and 
is also shown to down regulate the expression of several surface molecules essential for 
the immune system, i.e. MHC class I and CD4 at the plasma membrane. Vpr is known 
to arrest the cell cycle at the G2 phase. In addition Vpr has been associated with 
induction of cell death and is needed for efficient infection of HIV in macrophages 
(Bieniasz, 2009; Kirchhoff, 2010). 
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1.3.2  FUSION PROTEINS  
The best characterized fusion proteins are those of enveloped viruses and the cellular 
SNARE protein complex. The SNAREs are responsible for vesicle merging during 
intracellular trafficking and neurotransmitter release in nerve cells. The viral fusion 
proteins are membrane proteins that are used to merge the viral lipid membrane with a 
cell membrane, either at the plasma membrane or in intracellular vesicles, to release the 
viral genome into the cell. These systems are different in many aspects, but the 
mechanicstic outcome is the same, i.e. insertion of a fusion peptide into the target 
membrane followed by conformational changes within the proteins dragging the two 
membranes together for fusion. Below I will summarize the present knowledge about 
how viral fusion proteins function. 
 
1.3.3 VIRAL FUSION PROTEINS 
Enveloped viruses are surrounded by a lipid bilayer derived from the host cell during 
virus budding. This membrane shields the capsid with the genetic material of the virus 
until it is delivered into the cytoplasm of a new host cell to initiate an infection. The 
delivery takes place as membrane fusion event between the virus membrane and the 
membrane of the host cell. Virus membrane fusion can occur at the plasma membrane at 
neutral pH as in several retroviruses, were receptor (and possibly coreceptor) binding is 
the sole trigger for fusion. 
 
Table 4. 
Classification of viral fusion proteins 
• Class I Fusion active subunit (virus) 
Retrovirus TM (MLV) and gp41 (HIV) 
Orthomyxovirus HA2 (Influenza virus) 
Filovirus GP2 (Ebola virus) 
Coronavirus S2 (SARS virus) 
Paramyxovirus F1 (Simian virus 5) 
  
• Class II  
Flavivirus E (Dengue virus) 
Togavirus E1 (Semliki forest virus) 
  
• Class III  
Rhabdoviruses G (Vesicular stomatitis virus) 
Herpesvirus gB (Herpes Simplex Virus) 
 17 
 
 
 
Other viruses, e.g. influenza virus, have evolved to use receptor mediated endocytosis 
and entry then takes place in an endocytic compartment. These viruses frequently use 
acidic pH as a trigger for membrane fusion. Other variants of fusion triggering exist, 
e.g. ALV need both receptor binding and low pH and the Ebola- and SARS- viruses 
need proteolysis in the endosomes (Mothes et al., 2000; Chandran et al., 2005; 
Matsuyama et al., 2005; Simmons et al., 2005). Even though viruses use different entry 
strategies the function of the fusion protein is remarkable conserved.  
Most viral fusion proteins are made as precursors in the RER where they also form 
trimers. When the protein pass through the trans-Golgi cellular furin cleaves the 
precursor into two subunits, the N-terminal, peripheral subunit and the C-terminal 
transmembrane subunit. The peripheral subunit carries the properties needed for 
receptor binding to the host cell, whereas the transmembrane subunit carries the fusion 
activity. The peripheral subunit also suppresses the fusion potential stored in the 
transmembrane subunit (Fig 4A). However, receptor binding, and sometimes low pH, 
dissociates the peripheral subunit from the transmembrane subunit. This activates 
certain conformational changes within the transmembrane subunit. First an extended 
“pre-hairpin” trimer structure of the transmembrane subunit is believed to be formed. 
This inserts a hydrophobic domain, the fusion peptide, into the target membrane (Fig 
4b). Thereafter the prehairpin structure back folds upon itself, creating a “hairpin” 
trimer structure (post fusion structure). The back folding drags the two membranes 
together for membrane fusion (Fig 4C and 4D). The fusion proteins of the different 
viruses have been divided into different classes depending on what kind of secondary 
structure the transmembrane subunit is composed of. The Class 1 fusion proteins are 
characterized by a central α-helical coiled-coil structure in the transmembrane subunit, 
creating a six helical bundle upon hairpin formation. The class 2 fusion proteins are 
dominated by β-sheet structures in the fusion active subunit and the class 3 fusion 
proteins have a mixed secondary structure (Table 4).  The retroviruses carry class 1 
fusion proteins as does viruses such as orthomyxoviruses, paramyxoviruses, 
coronaviruses and filoviruses. The fusion protein of influenza virus, an orthomyxovirus, 
is called the hemagglutinin (HA) and is the classical example of a class 1 fusion protein. 
Both the native pre-fusion structure and the low pH activated post fusion structure of the 
HA have been solved using X-ray crystallography (Skehel and Wiley, 2000; Kielian and 
Rey, 2006; Harrison, 2008). 
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the N-terminal region of SU. The ∆H8 Env mutant is correctly processed and 
incorporated into virus particles. It also binds normally to receptors but it cannot 
complete the membrane fusion process (Bae et al., 1997). However, the infectivity of 
the receptor bound mutant virus can be rescued by adding soluble RBD of wt SU in 
trans (Lavillette et al., 2000). Thus, after receptor binding the mutant RBD makes a 
loose enough interaction to the rest of the spike that it can be replaced by receptor 
bound wt RBD, which can activate the spike. Indeed, it proved possible to delete the 
entire RBD and still rescue some fusion with soluble RBDs as long the receptor was 
present. The fusion was significantly enhanced if the membrane contact of the RBD 
deleted spike was restored, by replacing the RBD with the hormone erythropoietin, 
which is known to bind to the erythropoietin receptor. Apparently, the wt RBD becomes 
activated by receptor binding to interact with the CTD of the defective SU in a way that 
triggers fusion. The interaction has been suggested to involve a region in the major 
disulfide loop of the CTD (Barnett and Cunningham, 2001; Barnett et al., 2001; 
Lavillette et al., 2001). However, in the native spike it is important that the RBD 
maintains a type of interaction with the CTD, which suppresses TM activation. The 
stability of this interaction is crucial in preventing premature spike activation. One 
important factor stabilizing the native spike structure seems to be the PRR. This region 
is positioned in between the RBD and the CTD and contains a stretch of about 45 amino 
acids that are unusually rich in proline residues. It has been documented that PRR 
mutants can cause efficient spike mediated cell-cell fusion although the virus particles 
were noninfectious. The reason seemed to be decreased spike stability resulting in spike 
activation for fusion before being incorporated into virus particles (Lavillette et al., 
1998; Weimin Wu et al., 1998; Lavillette et al., 2002).  
But how is then TM activated by the RBD triggered CTD? The TM is disulfide linked 
to the CTD. This disulfide bridge originates in SU from a conserved redox acive 
isomerase motif (Fig 6 and 8.) containing two cysteines interspaced by two other 
residues (Cys-X-X-Cys, CXXC). One of the Cys residues in the motif carries a free 
thiol-group and the other is engaged in the disulfide bridge (Pinter et al., 1997; 
Opstelten et al., 1998). The CXXC motif controls MLV fusion by inducing 
isomerization of the intersubunit disulfide. Thus, upon receptor binding the reactive 
thiol group within the CXXC motif attacks the intersubunit disulfide bond causing its 
isomerization to a CXXC disulfide bridge. This leads to the dissociation of SU releasing 
the fusion potential stored in TM. According to the prevailing model the receptor 
activated RBD changes the locale of the CXXC thiol through its altered interaction with 
the CTD so that the thiol becomes deprotonated and can attack the intersubunit disulfide 
(Li et al., 2007). Interestingly, the free thiol-group in the CXXC motif becomes 
exposed, upon receptor binding, before the disulfide rearrangement. By adding an 
alkylator during fusion activation the free thiol group can be alkylated and is then not 
able to rearrange the disulfide bond between SU and TM. This traps the spike in an 
intermediate structure, an isomerization arrested stage (IAS), which can be reactivated 
by artificial reduction of the intersubunit disulfide using e.g. DTT. It was also shown 
that it 
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1.4.2 THE HIV-1 PERIPHERAL SUBUNIT, GP120. 
The HIV spike is a trimer of the peripheral gp120 subunit and the transmembrane gp41 
subunit. In contrast to MLV the subunits of HIV are not linked by a disulfide. The HIV-
1 gp120 is divided into five variable (V1-V5) and five constant (C1-C5) regions (Fig 6). 
The spike activation process is initiated when gp120 binds to CD4. This interaction 
induces conformational changes in gp120 that exposes and forms the coreceptor binding 
site, which is specific for the chemokine receptor CCR5 or CXCR4. Coreceptor binding 
to the CD4 activated gp120 is believed to weaken the interaction between gp120 and 
gp41, activating the latter for fusion (Sattentau and Moore, 1991). 
Several different crystal structures have been solved for the HIV gp120  (Kwong et al., 
1998; Huang et al., 2005; Zhou et al., 2007; Pancera et al., 2010). All of these proteins 
have been expressed as monomers. They all have large deletions, usually removing the 
V1-V2 and V3 variable loops and the flexible N- and C-terminal ends. These 
engineered proteins are referred as the gp120 core. Furthermore, the different core 
structures are stabilized by bound antibody Fabs and soluble CD4 fragments. The 
structures are overall similar but clear differences are seen when comparing the 
complexes. The first gp120 core structure to be solved using X-ray crystallography was 
in complex with CD4 and Fab 17b. The gp120 core showed a heart-like structure 
composed of an inner- and outer-domain connected by a bridging sheet (Fig 10, panel 
A) (Kwong et al., 1998). The inner domain was believed to interact with gp41 at the 
three fold axis of the trimeric spike whereas the heavily glycosylated outer domain with 
the CD4 binding site was thought to be exposed on the surface (Kwong et al., 1998).  
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The structure of gp120 core protein in complex with the broadly neutralizing antibody 
b12 has also been solved (Zhou et al., 2007). This gp120 core had five engineered 
disulfides and four substitutions in the CD4 binding site cavity to restrict interdomain 
movements and to stabilize the bridging sheets. This structure also displayed a heart like 
structure and the outer domain was almost identical compared to the CD4 bound 
structure. However, the region forming the bridging sheet in the CD4 bound structure, 
formed in the Fab b12 complex two β-sheets and a loop instead. Also there were some 
differences in the inner domain close to the bridging region. It was suggested that the 
b12 stabilized gp120 core structure resembled an unliganded spike and that CD4 
binding induced the formation of the bridging sheet (Zhou et al., 2007).  
Biochemical studies have shown that the bridging sheet and the V3 loop constitute the 
binding site for the coreceptor. Furthermore, the data suggested that the V1-V2 loops 
cover the V3 loop in the native spike and that CD4 binding causes displacement of V1-
V2 loops and exposure of the V3 loop for coreceptor binding (Sattentau and Moore, 
1991; Thali et al., 1993; Wyatt et al., 1995; Sullivan et al., 1998; Sanders et al., 2000).  
The structure of the gp120 core containing an intact V3 loop was solved in complex 
with CD4 and the Fab X5. This showed the same core structure as the other CD4 bound 
complex but the V3 loop formed a 30Å extension from the top of the gp120 core. 
Binding of gp120 to cell surface CD4 would position V3 so that its coreceptor binding 
tip points towards the target membrane (Huang et al., 2005).  
The gp120 core structure including stabilizing T257A and S375W substitutions and 
almost intact N- and C-terminal ends was most recently solved. This structure was 
complexed with CD4 and the Fab 48d. Again a similar CD4 bound gp120 core structure 
was seen and the N- and C-termini made a 30Å extension pointing downwards from the 
core toward the viral membrane (Pancera et al., 2010). In a related publication it was 
proposed that the N/C-extension interacted with gp41 as suggested by mutational 
studies. Furthermore, it was speculated that when both CD4 and the coreceptor binds to 
the outer domain of gp120 a conformational shift occurs and that this transfers an 
activation signal via the inner domain to the N/C-extension, regulating the interaction 
with gp41 and its fusion activity  (Finzi et al., 2010).  
A vaccine that targets gp120 could potentially block the infection, as in the case of 
influenza virus (Karlsson Hedestam et al., 2008). However, the production of a vaccine 
against HIV-1 has so far been unsuccessful and it has been suggested that the structural 
flexibility of gp120 is the reason. It has been shown using thermodynamic 
measurements that CD4 binding to gp120 causes large changes in its enthalpy and 
entropy. This was interpreted as a considerable conformational flexibility in gp120 and 
that CD4 binding caused extensive structural rearrangements into a more stabile 
structure. This flexibility is probably needed during fusion activation and is also an 
advantage for the virus to avoid the immune system (Myszka et al., 2000). One 
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predicted to form an α-helix (the C-helix) closer to the viral membrane (Fig 6). Peptides 
covering the N-helix and parts of the C-helix region have been crystallized and shown 
to form a trimeric N-helical coiled coil structure with the C-termini bent, like in a 
hairpin, interacting with the grooves of the N-helical coiled coil (Fig 11) (Fass et al., 
1996; Chan et al., 1997; Weissenhorn et al., 1997). These structures resembled the post-
fusion structure of the Influenza HA2. This supported an Influenza HA2-like fusion 
model where the N-helix of the transmembrane subunit is believed first to form an 
extended trimeric coiled coil (prehairpin) inserting the fusion peptide into the target 
membrane. Subsequently, the C-helixes fold into the grooves of the N-helical coiled coil 
forming a six helical bundled structure. This brings the target membrane and the viral 
membrane together for fusion. The model is supported by studies where parts of the N-
helix or especially the C-helix has been added in peptide form to activated spikes of cell 
bound virus and shown to inhibit virus fusion (Jiang et al., 1993; Chan et al., 1998; 
Furuta et al., 1998). Importantly CD4 and coreceptor interaction is needed for peptide 
binding in the case of HIV-1, suggesting, that the peptides only binds to a spike 
intermediate structure e.g. the gp41 prehairpin (Furuta et al., 1998; Abrahamyan et al., 
2003). Similarly, in the case of MLV it has been possible to bind fusion inhibiting TM 
peptides to IAS spikes, but not to native spikes (Wallin et al., 2006). However, it should 
be stressed that there is no structural data yet to support the existence of a prehairpin 
intermediate of the transmembrane subunit during retrovirus spike activation. 
In between the N-helix and the C-helix of the transmembrane subunit is the chain 
reversal region. This region is part of the hinge in the back-folded post-fusion crystal 
structures of this subunit. Closely downstream of the hinge MLV TM contains a 
conserved CX6CC motif. This is, with the last Cys of the motif, making the disulfide 
bond to the isomerization motif in SU (Pinter et al., 1997; Opstelten et al., 1998). The 
other two Cys residues of the motif are linked internally and therefore the region has 
also been called the disulfide loop region. It is interesting that the CX6CC motif is 
conserved among gamma retroviruses, delta retrovirus including HTLV, alfa 
retroviruses including ALV and also filoviruses including Ebola virus (Delos et al., 
2010). In the case of ALV and Ebola virus the motif is disulfide linked to SU, but the 
Cys in SU is not part of an isomierization motif. However, in the case of HTLV the SU 
Cys is part of an isomerization active CXXC motif (Li et al., 2008). These well 
conserved Cys residues in TM suggest a common function for this region in interacting 
with SU and also in controlling TM activation. Mutations inserted into the chain 
reversal region has also been shown to inhibit membrane fusion due to possible defects 
in back-folding (Maerz et al., 2000; Delos et al., 2010).  
HIV-1 contains a CX5C motif in the corresponding region of gp41. This is conserved 
among the lentivirus group. However, HIV-1 lacks the CXXC motif in gp120 as well as 
the intersubunit disulfide bridge. Nevertheless, the CX5C region is also known to 
interact with gp120 in the native HIV-1 spike. If the CX5C motif in gp41 is engineered 
into a CX5CC motif, this extra Cys can make a stable disulfide bond to a Cys introduced 
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in the C-terminal region of gp120 (Binley et al., 2000). This mutant is known as HIV-1 
SOS. Conformational changes within this spike mutant upon CD4 and coreceptor 
binding allows DTT mediated reduction of the disulfide bond, rescuing membrane 
fusion (Abrahamyan et al., 2003; Binley et al., 2003). Thus, the HIV-1 SOS can be used 
for trapping a receptor activated intermediate structure of the spike.  
 
The membrane proximal external region (MPER). 
The MPER is positioned immediately external to the viral membrane and contains about 
20-25 amino acids, many of which are Trp residues. The MPER has been extensively 
studied in the case of HIV-1. The peptide structure of the MPER has been determined 
but unfortunately this is in dispute. In one recent study it was shown that the MPER 
peptide was an L-shaped molecule with two amphipathic α-helixes separated by a hinge. 
The hydrophobic sides of the helixes were inserted into the viral membrane (Sun et al., 
2008). MPER peptides have also been observed in the form of an extended β-turn  and it 
has been suggested that both conformations exist but in different functional states of the 
spike (Ofek et al., 2004). In the trimeric spike the MPERs have been modeled to extend 
from a common TM stem along the membrane surface to the periphery. 
Deletions or substitution of amino acids within the MPER of viral spikes have been 
shown to affects viral fusion (Munoz-Barroso et al., 1999; Salzwedel et al., 1999). 
MPER peptides also bind to membranes and cause membrane leakage, like isolated 
fusion peptides do (Suarez et al., 2000a; Suarez et al., 2000b). These findings suggest 
that MPER has an active role in the membrane fusion reaction.  
The MPER is interesting for immunological reasons because two rare, broadly 
neutralizing, antibodies against HIV-1, 2F5 and 4E10, bind to this region. Surprisingly, 
these antibodies do not bind to native spikes but find their epitopes first after fusion 
activation (Ofek et al., 2004; Dimitrov et al., 2007; Alam et al., 2009). In addition it has 
been found that 2F5 and 4E10 has week affinity for membranes and that this ability is 
vital for their neutralizing effect. It was suggested that the membrane affinity 
concentrated 2F5 and 4E10 to the virus membrane, taking them into close proximity of 
the MPER and allowing quick epitope binding upon fusion activation (Alam et al., 
2009). NMR has been used to determine the structures of 2F5 and 4E10 Fab bound 
MPER. These showed that both antibodies bound the L-shaped peptide at the membrane 
interface and disrupted the structure of the hinge region between the two helices. It was 
speculated that the MPER hinge was vital for fusion and that 2F5 and 4E10 block this 
function (Song et al., 2009).  
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The membrane spanning domain  
The transmembrane domain (TMD) is composed of about 22 amino acids. One major 
function is to anchor Env to the lipid bilayer. However, the TMD is one of the most 
conserved parts of retrovirus Envs suggesting additional functions. In the case of HIV-1 
it has been shown that a GGXXG motif in the TMD is important for membrane fusion 
(Shang et al., 2008; Shang and Hunter, 2010). In bacteria a GGXXG motif has been 
suggested to be important for associations between transmembrane domains (Senes et 
al., 2004). Perhaps, GGXXG mediated interactions are involved in the viral fusion 
process. The GGXXG motif is not present in MLV, but it has been shown that a Pro 
residue in the TMD is important for fusion (Taylor and Sanders, 1999).  
 
The cytoplasmic tail 
All viral fusion proteins have a CT which can vary a lot in size, i.e. the CT of influenza 
HA contains 11 amino acids that of, MLV Env 32 amino acids and CT of the HIV-1 gp 
about 150 amino acids. Although the size variance is huge, they all have similar 
functions. The CTs are needed to interact with cellular and/or viral proteins that direct 
intracellular transport of the fusion protein and its incorporation into virus particles. For 
instance the unusually long CT of the HIV-1 spike binds to TIP47, which is needed for 
efficient spike incorporation into particles (Blot et al., 2003; Lopez-Verges et al., 2006). 
In addition the CT in most viral fusion proteins has been shown to control the fusion 
activity. The mechanism behind this is an important, but unresolved question. 
A good model system to study the function of the CT during membrane fusion was 
found in MLV where the viral PR, during virus particle maturation, cleaves the 16 
amino acids long R-peptide from the cytoplasmic tail of TM (Green et al., 1981; 
Henderson et al., 1984). The processing has been shown to be critical for the viral 
fusion function. This was shown by expressing full length Env and R-peptide deleted 
Env in cells and finding that the deleted Env caused membrane fusion between cells 
(Ragheb and Anderson, 1994; Rein et al., 1994). Thus, TM with the R-peptide 
represents a precursor form of Env which protects it from premature fusion activation, 
which is potentially harmful for the producer cell. During virus release the viral protease 
cleaves the R-peptide and activates the fusion potential in TM. The R-peptide cleavage 
is a conserved event among gammaretrovirus and has also been reported for the β-
retrovirus, MPMV, and the lentivirus, equine infectious anemia virus (Rice et al., 1990; 
Brody et al., 1994; Bobkova et al., 2002). It is not known how the R-peptide restrains 
membrane fusion, but several models have been suggested. Firstly, the R-peptide has 
been shown to be palmitoylated and it has been suggested that this targets the R-peptide 
to the inside of the plasma membrane, suppressing fusion (Olsen and Andersen, 1999). 
Secondly, It has been suggested that a host cell protein interacts with the R-peptide 
suppressing membrane fusion (Yang and Compans, 1997). However, no such protein 
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has been found so far. Thirdly, the R-peptide trimer in the spike has been suggested to 
form a helical coiled-coil structure stabilizing the spike in its mature, fusion suppressing 
state. This is supported by secondary structure modeling and mutations introduced to 
regions believed to stabilize the helical coiled-coil (Taylor and Sanders, 2003). Such 
destabilizing mutations rescued fusion in Env with R-peptides.This third model is also 
supported by the results of a study with the paramyxovirus fusion protein. In this a 
stabilizing trimerization motif was inserted into the C-terminal end of the 
transmembrane subunit and it was found that this restricted its folding into the six 
helical structure upon activation. It was speculated that that CT trimerization prevented 
rotations in the plane of the membrane making it impossible for the C-helix region to 
back fold into the grooves of the trimeric N-helical coiled-coil (Waning et al., 2004).  
Some more hints to the mechanism by which the R-peptide exerts its function in the 
MLV spike was achieved by biotinylation and epitope mapping of the spike surface. It 
was found that R-peptide cleavage induced significant changes in the spike ectodomain 
(Aguilar et al., 2003). Finally, video fluorescence microscopy and electrical capacitance 
measurements have been used to investigate the formation of fusion pores created by 
the MLV spikes with and without the R-peptide. It was shown that R-peptide containing 
spikes were unable to create fusion pores on receptor positive host cells. It was 
concluded that the R-peptide suppresses spike mediated fusion before the lipid mixing 
and hemifusion stage (Melikyan et al., 2000).  
In HIV-1 the long CT of the spike has been shown to affect fusion in many ways. First, 
deletions of the spike CT has been shown to increase fusion efficiency of the virus 
(Edwards et al., 2002; Wyss et al., 2005). Secondly, using immature particles with 
uncleaved Gag it has been shown that the spike CT interacts with the Gag layer below 
the membrane and that this suppresses the fusion function of the spike. Deletion of the 
CT releases this block (Davis et al., 2006; Wyma et al., 2004; Wyma, Kotov, and Aiken, 
2000). Thirdly, an interesting observation has been that HIV-1 treated with a cholesterol 
binding compound that blocks virus entry, amphotericin B methyl ester (AME), quickly 
developed resistance. This was shown to be caused by a single amino acid substitution 
leading to cleavage of the CT by the viral PR (Waheed et al., 2007; Waheed et al.). 
Interestingly, no stop codon deletions of CT were observed. Given that the viral 
protease is active during or soon after budding this suggests that the full length of the 
CT was needed for synthesis, transport and gp incorporation. However, the CT cleavage 
was favorable for the virus particle upon fusion. It is possible that AME stabilizes the gp 
trimer in its native prefusion state or restricts spike mobility in the membrane, which is 
needed for fusion activation, and that CT cleavage releases this fusion inhibitory effect.  
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1.4.4 THE STRUCTURE OF THE RETROVIRUS SPIKE 
The first structure of a retrovirus spike was reported for MLV in 2005. This was 
resolved using the combination of cryo electron tomography of virus particles and 
single particle analysis of spike subvolumes. The native MLV spike was found to carry 
multiple projections in its head region and it was standing on the membrane with tripod 
legs (Forster et al., 2005). In 2006 there were two different structures published on the 
native spike of Simian immunodeficiency virus (SIV). The spike in these studies 
contained a truncated CT to increase spike incorporation into virus particles (Zanetti et 
al., 2006; Zhu et al., 2006). However, even though similar methodology was used the 
final structures were very different from each other. Zhu et al. presented a structure with 
a compact head standing on three legs and Zanetti et al. showed a mushroom like spike 
structure with a compact head connected to the viral membrane by a stalk suggested to 
contain gp41. The first 3D reconstructions of native and CD4 bound HIV-1 spike 
structures were reported by the group of Subramaniam in 2008 (Liu et al., 2008). The 
unliganded spike in this study represents today’s paradigm of the in situ HIV spike 
structure. This contained a hollow head connected to the viral membrane by a compact 
stem. In the head region the protomeric units formed blade-like lobes on the sides and 
interprotomeric connections at the three fold axis at top. The atomic structure of the 
gp120 core from its complex with b12 Fab could be fitted into the lobe, such that the 
stems of the truncated V3 and the V1-V2 loops pointed toward the top of the head. The 
putative gp41 binding region of the gp120 core inner domain was pointing towards the 
lower parts of the head. The known glycosylation sites were all exposed to the external 
side and the CD4 binding region was located on the concave side of the lobe. In this 
way the fitting of the core gp120 structure validated part of their head structure (Liu et 
al., 2008). However, the crystal structure of gp120 core including its N- and C-terminals 
did not fit into their spike structure (Pancera et al., 2010). In particular the N/C 
extension known to interact with gp41 was located outside the stem, questioning this 
part of the EM structure. CD4 binding to the spike in the virus could not be studied 
without the stabilization of the complex with the 17b Fab. It was observed that the CD4 
and Fab binding caused a significant rotation of the gp120, which opened up the roof of 
the cavity in the head. This was suggested to facilitate the interaction of the gp41 
prehairpin with the cell membrane. 
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2. AIMS OF THE STUDY 
Retroviruses incorporate their genome into the host cell DNA and once the cell becomes 
infected it will continue to be so during its existence. Thus, a strategy towards an 
absolute prevention of retrovirus infection is to block the virus before it enters the cell 
by membrane fusion. I am trying to understand the structural transitions of the retrovirus 
fusion protein during fusion activation. This will increase the chances to find a definite 
prevention against retroviral infections. 
 
The aims of this study have been to find out: 
• If the intersubunit disulfide bond isomerization between SU and TM of MLV 
represents a receptor activated event that is necessary for virus induced 
membrane fusion (paper I). 
• If the R-peptide cleavage of MLV Env is needed for the SU-TM disulfide 
isomerization reaction (paper II). 
• How the R-peptide cleavage is synchronized in MLV Env trimers (paper III). 
• The structure of native HIV-1 gp trimer and its conformational changes upon 
CD4 receptor binding (paper IV). 
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3.  MATERIAL AND METHODS 
 
3.1  CELLS 
Human embryonic kidney 293T cells were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 4.5 g/liter glucose (Invitrogen, Paisley, UK) supplemented 
with sodium pyruvate, nonessential amino acids (Invitrogen), L-glutamine, and 10% 
fetal calf serum (FCS). The XC cells originated from a Rous sarcoma virus induced rat 
tumor and were maintained in DMEM containing 1 g/liter glucose (Invitrogen) 
supplementaed with L-glutamine, and 10% FCS. The NIH 3T3 mouse embryonic 
fibroblast cells (3T3) were maintained in DMEM containing 4.5 g/liter glucose 
supplemented with L-glutamine, and 10% FCS. The MOV-3 cell line is a 3T3 cell line 
that is chronically infected by Mo-MLV. This was obtained from G. Schmidt, GSF-
National Research Center for Environment and Health, Neuherberg, Germany. The 
MOV-3 cells were maintained as the 3T3 cell line. 
 
3.2 ANTIBODIES 
The anti R-peptide antibody, αR, is an affinity-purified polyclonal antibody from rabbits 
immunized with a 17 amino acids long peptide corresponding to the Mo-MLV R-
peptide, NH2-CVLTQQYHQLKPIEYEP-CONH2. An extra Cys was added to the N-
terminus as a conjugation site (Innovagen, Lund, Sweden). The Mo-MLV-specific 
rabbit antiserum, αMLV (HE863), and the Mo-MLV SU-specific rabbit antiserum, αSU 
(HE699), originated from Viromed Biosafety Laboratories, Camden, NJ. The antibody 
against the influenza of HA tag (YPYDVPDYA) was from Roche (Basel, Switzerland). 
The HIV-1 17b monoclonal antibody targets a CD4 induced epitope in gp120 and 
originate from NIH AIDS research and reference reagent program: From James E 
Robinson.  
 
3.3 REAGENTS OF SPECIAL ATTENTION 
N-Ethylmaleimide (SIGMA-Aldrich Chemie, Munich, Germany) (NEM) is a 
membrane permeable alkylating reagents that binds covalently to free thiol groups (-
SH), e.g. present in Cys residues. Cys residues in proteins can form disulfide bonds 
between their thiol groups (-S-S-). MLV SU contains an isomerase motif (CXXC), were 
one Cys is covalently attached to TM and the other carries a free thiol group. Upon 
spike activation the free thiol becomes exposed, attacking the SU-TM disulfide and 
isomerizes it to an intra CXXC disulfide bond (Fig 13, A-C). NEM is able to bind to the 
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interphase. To produce radio labelled virus, 50 μCi/ml [35S]-Cys was added to DMEM 
medium containing 5% FCS and depleted in Cys. Labelled virus was then purified as 
described. 
To create mutated MLV the plasmid pNCA (obtained from Stephen Goff, Columbia 
University, New York, NY) encoding the full-length Mo-MLV genome was used. Two 
separate PCRs were performed to introduce the mutation into two overlapping DNA 
fragments and these were joined in a fusion-PCR. The mutated fragment was then 
cleaved by restriction enzymes and purified using a gel extraction kit, before ligation at 
16 °C overnight with T4 DNA ligase into the correspondingly cleaved pNCA plasmid. 
E.coli JM109 were transformed with the ligated DNA for 30 min on ice. Thereafter the 
samples were heat-shocked at 37 °C for 30 seconds. The bacteria were seeded on LB-
agar plates containing 50 μg/ml ampicillin and incubated overnight at 37 °C. Colonies 
were collected and screened using DNA sequencing. 293T cells were then transfected 
with 20 μg of the proviral DNA in a 75 cm2 flask using calcium phosphate 
coprecipitation. Virus labeling and purification were performed as above. 
To produce HIV-1 virus like particles (VLP), one 150-cm2 flask with 293T cells was 
transfected with 20 μg pCAGGS JR-FL gp160 SOS ΔCT and 20 μg pNL4-3.Luc.R-E- 
(pNL) DNA using calcium phosphate coprecipitation. The gp160SOSΔCT DNA 
encodes the HIV-1 gp with an intersubunit disulfide and a gp41 endodomain deletion. 
The pNL DNA encompasses an HIV-1 genome with env and vif truncations, a frame 
shift mutation in the vpr gene and the luciferase gene in place of nef. VLP labeling and 
purification were performed as above. 
For EM-analyses of HIV-1 spikes, ten 150-cm2 flasks with 293T cells were transfected 
as described. VLPs were collected in the culture medium from 8 h to 48 h after 
transfection and then purified and concentrated in several steps at 4 °C. First, the 
medium (110 ml) was clarified by low-speed centrifugation for 10 min at 8 krpm in a 
JS13.1 rotor (Beckman Instruments, Brea, CA US). VLPs in the supernatant were 
purified by sedimentation in parallel step gradients, where 25 ml clarified medium was 
layered on top of 7 ml 20% (weight ⁄ weight) and 3 ml 60% (weight ⁄ weight) sucrose in 
HNC buffer (50 mM Hepes, 100 mM NaCl, 1.8 mM CaCl2, pH 7.4) and centrifuged for 
2 h at 22 krpm in an SW 28 rotor. The 20%/60% interphases with VLPs were pooled 
and sucrose removed by overnight dialysis against 1 liter of HNC in 0.5-3 ml Slide-A-
Lyzer cassettes (molecular weight cutoff, MWCO, 20 kDa) (Pierce, Rockford, IL USA). 
The sample was concentrated in an Amicon Ultra 15 (MWCO = 100 kDa) centrifugal 
filter device (Millipore, Billerica, MA US), to a final volume of about 100 μl. To isolate 
the spikes, samples were lysed in HNC buffer containing 2% TX-100 for 10 min at 37 
°C and then subjected to sedimentation in a linear 5–20% (weight ⁄  weight) sucrose 
gradient, in HNC containing 0.05% TX-100, superimposed by a 0–0.2% (weight ⁄ 
weight) glutaraldehyde gradient, at 28 krpm for 18 h at 4 °C in a SW 55 rotor. The 
gradient was fractionated from the top into 13 fractions (50 μl), and analyzed by blue 
native (BN)-PAGE and silver staining. Sucrose was removed in a Zeba desalt spin 
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column (Pierce) for the fractions containing pure trimers. The sample was finally 
concentrated in a centrifugal filter device Microcon YM 30 (MWCO = 30kDa) 
(Millipore) and used for EM analyses. 
 
3.5 SDS- AND BN-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a method 
used to separate proteins according to their electrophoretic mobility. Since SDS binds to 
the entire polypeptide chain, samples end up with approximately identical charge per 
unit mass of polypeptide. Thus it is possible to separate proteins mainly due to size. The 
SDS-PAGE is not suitable for following protein complexes in the electrophoresis, 
because SDS efficiently disrupts noncovalent protein interactions. To follow protein 
complexes, i.e. HIV-1 spikes, the blue native polyacrylamide gel electrophoresis (BN-
PAGE) protocol has been used. Commasie brilliant blue binds to protein complexes 
without disrupting them and provide the necessary charges for the electrophoretic 
separation. 
 
3.6 MLV FUSION ASSAYS 
There are two main assays, fusion-from-within and fusion-from-without, to follow the 
membrane fusion activity of viral spikes. The Fusion-from-within assay refers to the 
methodology where viral spikes are expressed in a cell line, in the absence of other viral 
proteins. The function of the spikes is then followed by mixing the spike expressing 
cells with cells expressing viral receptors. Spikes binds to receptors and membrane 
fusion take place between spike- and receptor-expressing cells (Fig 15, left column).  
It is also possible to add virus particles to confluent cells that express the viral receptor. 
Some cell bound virus particles will be able to interact with two separate cells in close 
proximity to each other. Upon fusion, these virus particles will merge the membranes of 
the two cells together. This methodology is referred to as fusion-from-without (Fig 15, 
right column). With the fusion from without assay it is possible to follow the fusion of a 
synchronized activation of cell bond virus particles if the virus has been bond at 4 ˚C 
and then incubated at 37 ˚C. This is not possible with the fusion from within assay 
where spikes are continuously synthesized. The downside of the fusion-from-without 
assay is the low amount of fusion events compared to the fusion-from-within assay. 
Fig 15
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whereas the other carries a free thiol group (-SH) (Pinter et al., 1997; Opstelten et al., 
1998). Upon receptor binding the free thiol in the CXXC-motif becomes exposed and 
activated to isomerize the SU-TM disulfide. The receptor mediated isomerization 
releases SU from TM, thus triggering the fusion activity of TM. If an alkylating agent is 
added during fusion activation this modifies the exposed thiol in the CXXC-motif 
before isomerization takes place and traps SU and TM in an isomerization arrested and 
disulfide linked stage (IAS). Notably, the native spike cannot be alkylated at this 
position, i.e. the IAS spike represent an intermediate form of the receptor triggered 
spike (Wallin et al., 2004). 
In this thesis different kinds of SU-TM disulfide bond isomerization assays have been 
used and they are all depending on the finding that detergents such as NP-40 and Triton 
X-100 are strong inducers of SU-TM disulfide isomerization in vitro. If detergent is 
added to Mo-MLV and the mixture is incubated at 37˚C for 30 min, the intersubunit 
disulfide of all spikes rearrange and all SU-TM complexes dissociate and migrate 
separately as free SU and TM on nonreducing SDS-PAGE. If NEM is present during 
the detergent induced isomerization, SU and TM maintains the covalent bond and 
migrate as a SU-TM complex because the isomerization active thiol will be blocked by 
alkylation. In this way it was possible to follow the SU-TM disulfide bond 
isomerization reaction biochemically. 
 
Receptor mediated isomerization of the intersubunit disulfide in the spike. 
Purified radiolabelled Mo-MLV was diluted in HNC buffer containing 20 μg/ml 
polybrene and spinnoculated onto XC cells at 4 ˚C. Free virus was washed away and 
pre-warmed (37°C) HNC buffer was added. The cultures were then incubated for 
different times at 37 °C, allowing receptor induced activation of viral spikes for fusion-
from-without. The virus-cell samples were then put on ice to stop the reaction. 
Thereafter, HNC buffer containing detergent and NEM was added and the samples 
incubated for 30 min at 37 °C. This treatment trapped all unactivated SU-TM 
complexes covalently together at the IAS. The amount of receptor induced SU-TM 
disulfide isomerization could be quantified in nonreducing SDS-PAGE by relating the 
amount of free SU to the amount of SU and TM in covalent SU-TM complexes. 
 
Receptor mediated formation of spikes at the IAS. 
Purified radio labelled MLV was diluted in HNC buffer containing 20 μg/ml polybrene 
and spinnoculated onto XC cells at 4 ˚C. Non-bound virus particles were washed away 
and pre-warmed (37°C) HNC buffer containing 2 mM M135 was added to initiate the 
fusion reaction. The cultures were then incubated for different period of times at 37 °C. 
At these conditions all receptor activated spikes will be trapped at the IAS. Samples 
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were put on ice to stop the reaction and then washed thoroughly to remove all excess of 
M135. HNC buffer containing detergent was added and the samples incubated 30 min at 
37 °C. This isomierized the intersubunit disulfide in all SU-TM complexes that were not 
previously receptor activated and trapped at the IAS. The amount of spikes at the IAS 
was possible to quantify in nonreducing SDS-PAGE by relating the amount of disulfide 
linked SU-TM complexes to the amount of free SU.  
 
In vitro triggering of the SU-TM disulfide isomerization reaction. 
The MLV spike shows a very inefficient receptor independent isomerization of the 
intersubunit disulfide at 37 ˚C. This reaction can be much enhanced if the spike is Ca2+ 
depleted. Therefore, incubation of virus in Ca2+ free buffer provides conditions for an in 
vitro intersubunit disulfide isomerization reaction. This can be potentiated by increasing 
the pH of the buffer or if the Ca2+ chelating agent EDTA is included. Thus, purified 
radiolabelled Mo-MLV particles were diluted in HN buffer (pH 8.0) lacking Ca2+ and 
incubated for 0-5h at 37 °C, allowing in vitro isomerization of the SU-TM disulfide. 
Detergent and NEM was then added to the samples, followed by a 30 min incubation at 
37 °C, to trap all unactivated spikes at the IAS. The samples were then analyzed by non-
reducing SDS-PAGE. The amount of in vitro induced SU-TM disulfide isomerization 
was quantified by relating the amount of free SU to the amount of SU-TM complexes. 
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3.8 PROTEIN STRUCTURE DETERMINATION 
3.8.1 ELECTRON MICROSCOPY VERSUS X-RAY CRYSTALLOGRAPHY AND NMR. 
For structural determination of proteins there are several techniques to choose from, X-
ray crystallography, nuclear magnetic resonance (NMR), single particle cryo-EM and 
cryo-EM tomography. The different methods all have their benefits and limitations. X-
ray crystallography is the most commonly used method and it determines the 
arrangement of atoms inside a crystal structure by studying the diffraction patterns of X-
rays. This method has been used to solve the structure for many different proteins at a 
resolution down towards 1Å. Limitations include the requirements of high protein 
concentration and purity, and the protein needs to form a well organized crystal for data 
collection. These organized crystals are rarely formed for larger proteins and protein 
complexes, due to structural flexibility and heterogeneity. NMR is another high 
resolution method to determine protein structures and it is based on isotope labeling, i.e. 
13C or 15N. In a high magnetic field it is possible to track the isotope labelled atoms and 
calculate their positions in a 3D structure. NMR is very useful for proteins that do not 
form crystals and the main drawback is that it only works for relatively small proteins, 
usually smaller than 35 kDa. Thus, both X-ray crystallography and NMR do have 
downsides when working with large proteins and protein complexes. One strategy to 
circumvent these limitations has been to solve the structures of separate domains of 
larger proteins or stabilize the protein by deletions or by introducing structural 
modifications. This in turn raises questions about how these changes affect the structure 
of the protein.  
Transmission electron microscopy (TEM) is the best suited technique to study the 
structure of intact protein complexes that are unable to form crystals. TEM can be 
divided into different approaches, single particle analyses and tomography. The 
principle of TEM includes the usage of free electrons that are discharged towards an 
ultra thin specimen and electrons passing through the sample are registered. This works 
much in the same way as light registers to a camera film. The advantage of using 
electrons is their short wavelength, compared to visible light, allowing smaller detailed 
to be visualized. One problem with exposing biological samples to doses of electrons is 
destruction of the sample. This has been solved either by using different stain 
techniques or freezing. Stains provide a protected shield over the organic tissue or 
protein sample. However, this severely limits detection of smaller details and also could 
destroy the native protein structure. To collect high resolution EM data and preserve the 
native protein structure, samples can be plunge frozen into liquid ethane causing water 
to form vitreous ice. This rapid freezing avoids ice crystals that otherwise destroys the 
sample. Data collected from vitrified samples need to be gathered during low electron 
dose not to demolish the organic sample. This method is known as cryo-EM. Using the 
single particle approach proteins are purified and vitrified in soluble form, and it is 
assumed that they obtain a random orientation in the sample. This is necessary to 
reconstruct the 3D structure of the particles from 2D particle images seen on the 
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micrographs. The information from one particle is limited and in general thousands up 
to hundreds of thousands of particles are selected. Thereafter, particles are classified 
into groups of images with the same appearance. The average density of each class is 
then used for reconstructing a 3D density map of the protein. EM single particle 
analyses are well suited for large soluble protein complexes and in favorable situations 
it is possible to reach resolutions about 4Å, like in the case of the prototypical type 1 
chaperonin, GroEL (Ludtke et al., 2008). However, this methodology is not suited for 
proteins in an intact membrane because the membrane interaction excludes random 
orientations of particles.   
In EM-tomography the sample is tilted step wise, collecting data from the same particle 
at each tilt step (usually covering ± 65˚). The advantage of this approach is that the 
structure of one single molecule or cellular organization can be reconstructed in 3D 
without averaging with other particles. Therefore, tomography has been used to 
determine the structure of proteins in membranes. The disadvantage with tomography is 
that tilting cannot cover all angels resulting in missing data. This phenomenon is known 
as the missing wedge and has to be correlated in the final 3D reconstruction. Another 
drawback is the limitation in resolution, mostly due to poor signal to noise ratio, that in 
the best case reaches about 25-30Å. Recently the methods of tomography and single 
particle analysis have been combined. This approach has especially been used to resolve 
the structure of the retrovirus spike in intact virus particles. EM tilt series of virus 
particles are collected and these are used to create a 3D model of the particle. From this 
subvolume of spikes are chosen and used for averaging to increase the resolution, which 
can reach about 18-20Å. Even if the final result do not reveal the atomic or even the 
secondary structure, a detailed structural map can still be obtained by fitting of parts or 
domains of the protein that have been solved with a high resolution method. (Frank, 
2002; Roux and Taylor, 2007; Bartesaghi and Subramaniam, 2009; Spahn and Penczek, 
2009). 
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3.8.2 CRYO-EM DATA COLLECTION.  
HIV-1 spikes were isolated and samples (4 µl) applied to glow-discharged copper grids, 
with a thin holey carbon film mounted in a Fei VitrobotTM. After 40 s adsorption the 
grids were blotted once (3 seconds at zero offset) and plunge frozen in nitrogen cooled 
liquid ethane. All EM data was recorded in a JEOL2100F field emission gun 
transmission electron microscope, at 200 kV accelerating voltage and a magnification of 
43,300, with a 4K x 4K CCD camera (Tiez Video and Image processing System) using 
15 µm pixel size. This corresponds to 3.5 Å at the specimen level. All data were 
collected under low dose conditions (~10 e/Å2) using underfocus values in the range 
2.5-6 µm. The best pictures are obviously taken in perfect focus. However, cryo-EM of 
biological samples in focus produces little contrast making it impossible to track the 
particles. By taking pictures somewhat underfocused the phase contrast is increased 
making it possible to imagine the particles. The underfocus also leads to a systematic 
alteration of the image data and this alteration is described as the contrast transfer 
function (CTF), which needs to be corrected for each individual image during the data 
processing.  
 
3.8.3 SINGLE PARTICLE DATA PROCESSING.  
Image processing and 3D reconstructions were done in the EMAN package version 1.9 
using standard single particle procedures (Ludtke et al., 1999). For each reconstruction 
about 3,000-10,000 particles, i.e. 2D images of protein complexes, were selected and 
visually verified in boxer. The particles were corrected for CTF by phase flipping using 
ctfit and used to generate an initial 3D model in startcsym. The initial model was refined 
by iterative rounds of alignment, classification and averaging until no further 
improvement could be achieved. In the process each round results in a new 3D model 
which is used to prime the following round of refinement. As the retroviral spikes were 
isolated as homotrimers a 3-fold symmetry was imposed throughout the reconstruction. 
To estimate the resolution of the final 3D reconstruction the particles were randomly 
split in two sets, assembled into individual 3D models and compared using a Fourier 
shell correlation curve (FSC) in eotest. The resolution was taken as the point where the 
FCS curve reached 0.5. The final 3D reconstructions were low pass filtered to remove 
information beyond the estimated resolution. 
 
3.8.4 MOLECULAR MODELING.  
In order to obtain a more detailed picture of the spike structure several different high 
resolution atomic models of the gp120 core protein were fitted into the EM derived 3D 
models (density maps) of the unliganded and CD4-bound JR-FL gp160SOSΔCT spike. 
To this end the gp120 core structure was extracted from (1) its complex with the b12 
Fab (PDB NY7), (2) its complex with CD4 and X5 Fab (PDB 2B4C) a structure which 
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contain the V3 loop and (3) its complex with CD4 and 48d Fab (PDB 3JWD) which 
encompass the intact N- and C-terminal ends of the gp120. The fitting was done in the 
program O and was guided by overall shape similarity at a series of density thresholds. 
As a control the fitting was repeated using the fit in map utility in the program Chimera. 
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4.  RESULTS AND DISCUSSIONS 
 
4.1 KINETIC ANALYSES OF THE SURFACE-TRANSMEMBRANE DISULFIDE 
BOND ISOMERIZATION-CONTROLLED FUSION ACTIVATION PATHWAY IN 
MOLONEY MURINE LEUKEMIA VIRUS (PAPER I). 
Previously it was shown that isomerization of the covalent bond between SU and TM 
was required for MLV membrane fusion (Wallin et al., 2004). The major evidence for 
this was the finding that receptor binding exposed the isomerization active thiol of the 
CXXC-motif of SU for modification by alkylation. This arrested the activation process 
of the spike at an intermediate state called the isomerization arrested stage, IAS, which 
could be rescued by external reduction of the intersubunit disulfide with e.g. DTT 
(Wallin et al., 2004). However, the direct receptor induced isomerization of the SU-TM 
disulfide had not been demonstrated. Further, the isomerization reaction as well as the 
process of thiol exposure had to be correlated with the membrane fusion reaction. 
To demonstrate receptor-triggered SU-TM isomerization directly [35S]-Cys labelled 
Mo-MLV were bound to receptor positive XC cells and to receptor negative DF-1 cells 
for 1h in the cold (4°C). The cultures were then incubated in fusion activation buffer for 
different times (0-40 min) at 37°C. During this time receptor bound Envs were triggered 
for isomerization and fusion activation. Thereafter, samples were lysed with NP-40 
supplemented with M135. At these conditions all Envs, that had not been receptor 
activated were induced to isomerize but blocked by alkylation. Detergents like NP-40 
and Triton X-100 are very strong inducers of SU-TM disulfide isomerization in vitro. 
Viral proteins were captured using immunoprecipitation and analyzed by SDS-PAGE at 
non-reducing conditions. The receptor triggered isomerization was followed by the 
decrease of SU-TM complexes and the increase of free SU and TM. It was found that 
the intersubunit disulfide isomerized with time on XC cells but not on DF-1 cells. 
Maximally about 30% of SU-TM isomerized. Importantly the isomerization kinetics 
correlated with the fusion kinetics that had been determined before. This showed that 
the receptor binding to Env resulted in SU-TM disulfide rearrangement and that the 
disulfide isomerization reaction was an integrated part of the spike activation 
mechanism. 
We then analyzed the kinetics of formation of the alkylated, isomerization-blocked Env. 
[35S]-Cys labelled Mo-MLV was bound to receptor positive rat XC-cells for 1h in the 
cold (4°C). The cultures were then incubated in fusion activation buffer containing 
M135 at 37°C, chasing Env to the alkylated form. After different times (0-40 min) cells 
were put on ice and M135 was carefully washed away. Thereafter samples were lysed in 
NP-40 lysis buffer, which triggers isomerization in all Envs that had not been trapped at 
IAS, i.e. receptor activated and blocked by alkylation during the 37°C incubation. The 
amount of Env at IAS was followed by immunprecipitation of the Envs and analyses of 
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complexed and isomerized (free) forms of the SU and TM subunits using nonreducing 
SDS-PAGE. We found up to 12% of Env as alkylated, isomerization arrested Env. Most 
significantly, the kinetics of Env alkylation followed the fusion kinetics. This suggests 
that the alkylated Env represented a true fusion intermediate.  
The fusion kinetics observed for XC cell bound Mo-MLV should reflect the time it 
takes for the individual virus particles to form complete fusion sites. The receptor 
activation of SU-TM, in the presence of M135, generates IAS intermediates with the 
same kinetics as the fusion reaction. This suggests that SU-TM complexes at IAS 
should be assembled in arrested fusion sites. To test this possibility we analyzed the 
fusion kinetics after releasing the fusion activity stored in the IAS complexes. This was 
done by artificially reducing the intersubunit disulfide bound using DTT. According to 
our model we expected a rapid and synchronized release of the arrested fusion activity. 
Virus particles were bond to XC cells and then incubated for 15 min at 37˚C in the 
presence of M135. After washing M135 away, the samples were incubated for 1 to 15 
min at 37˚C in the presence of DTT. The virus spikes were then inactivated by pH 3.0 
treatment and the DTT-released fusion activity measured by following virus mediated 
cell-cell fusion. The analysis showed that already 1 min of incubation was enough for 
maximal fusion rescue. The fusion efficiency corresponded to about 70% of that of a 
nonarrested control virus. The 1 min DTT incubation was also shown to be sufficient 
for reducing the SU-TM disulfide of [35S]-Cys labelled MLV containing receptor 
activated IAS spikes on XC cells. These results suggest that the SU-TM complexes of 
IAS intermediate spikes are located in arrested fusion sites. 
In this study we also investigated how the stage of isomerization arrest related to that of 
hemifusion between the outer leaflets of the viral and cell membranes. For this purpose 
the drug chlorpromazine (CPZ) was used. CPZ lowers the energy needed for 
membranes to fuse. Thus, the stage of hemifusion proceeds effortlessly into complete 
fusion. First the effect of CPZ was investigated in our nonarrested fusion assay. To this 
end virus was bound to XC cells and incubated for 1 min at 37˚C with or without CPZ. 
This was followed by 15 min incubation at 37˚C without the drug. At this stage most 
viruses should have fused with the cells. Any remaining virus was inactivated by the pH 
3.0 wash and cultures were incubated at 37 ˚C to reveal polykaryons of cells fused by 
the virus. These were used to measure viral fusion efficiency.  It was observed that the 
sample incubated with CPZ had about 5 times more membrane fusion than the control. 
This showed the potency of CPZ to increase fusion, but could it rescue the membrane 
fusion activity of the spike at IAS? To find out, virus particles were bound to XC cells 
and incubated for 15 min, at 37˚C, in the presence of M135. Thereafter, cells were 
incubated with and without CPZ, followed by pH 3.0 inactivation and further incubation 
for polykaryon formation. No cell-cell fusion was detected in the sample treated with 
CPZ, meaning that the IAS intermediate Env does not induce hemifusion between the 
viral and the cell membrane. Thus the IAS intermediate has been arrested at a stage 
before lipid mixing. 
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One interesting notion in this work was the difference in amount of receptor activated 
Env in different assays. Maximally 12% of activated Env was detected as IAS after a 30 
min incubation of virus on XC cells in the presence of M135. When isomerization was 
followed directly, up to 30% of the spikes were found to be activated. How can we 
explain this discrepancy? One explanation could be that one Env trimer binds only to 
one receptor. When M135 is present this will only alkylate the subunit that actually 
bound to the receptor whereas the other two subunits remain unactivated and will not 
form the IAS. In the direct isomerization assay the receptor also binds to one SU, but 
then activates the other two subunits in the trimer in trans, leading to isomerization of 
all three subunits. This activation model is somewhat similar to how soluble RBD can 
rescue the function of the ∆H8 spike mutant of Mo-MLV. An alternative explanation is 
that the fusion of the viral membranes with the cell membrane, that follows the direct 
isomerization, but not IAS formation, could potentially lead to unspecific isomerization 
of the SU-TM disulfide.  
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4.2 R-PEPTIDE CLEAVAGE POTENTIATES FUSION-CONTROLLING 
ISOMERIZATION OF THE INTERSUBUNIT DISULFIDE IN MOLONEY MURINE 
LEUKEMIA VIRUS ENV (PAPER II). 
The finding in our group that MLV Env fusion is controlled by rearrangement of the 
covalent bond between SU and TM raised the intriguing possibility that R-peptide 
cleavage is needed for isomerization and the subsequent fusion activation. This 
possibility was investigated by creating mutations previously known to inhibit R-
peptide cleavage using fusion-PCR. Substitution mutations, L649V (LV), L649I (LI), 
L649R (LR) and V650I (VI) were inserted into Env of the complete Mo-MLV provirus 
(pNCA) (Colicelli and Goff, 1988). Virus particles were produced by calcium 
phosphate/DNA coprecipitation-transfection into 293T cells. Virus particles were 
collected between 24-48 h post transfection from the cell medium. Env incorporation 
into particles and R-peptide cleavage were analyzed for the different mutants using 
[35S]-Cys labelled particles. The virus was purified in a sucrose step gradient and 
analyzed by SDS-PAGE. The mutants and wt virus were found to be produced in 
similar amounts and all, but VI, contained corresponding amounts of Env. VI contained 
63% of the amount of Env that was incorporated into wt virus. The LI, LV and LR 
mutants were significantly inhibited in R-peptide cleavage as compared to wt. In 
contrast, VI was cleaved as wt virus. 
The fusion efficiency of the mutant viruses were tested using the virus dependent cell-
cell fusion assay (fusion-from-without). The virus was bound to XC cells by 
centrifugation at 850 x g for 1 h at +4 °C and then incubated at 37 °C for 30 min. Under 
these conditions competent virus will fuse with the cells and mediate cell-cell fusion. 
The spikes of non-fused virus were inactivated by a low pH (pH 3.0) wash and the cells 
were further incubated for 3 h at 37 °C to facilitate polykaryon formation between fused 
cells. Polykaryons were used to calculate the fusion efficiencies of the mutants relative 
to that of wt. We found that the R-peptide cleavage inhibited mutants were significantly 
inhibited in fusion. The infectivities of the mutants were tested using a similar assay. 
However, after the low pH inactivation step the cells were trypsinized, seeded on 
coverslips and incubated for 16 h at 37 °C and screened for infection by 
immunoflourescense using an anti Gag monoclonal antibody. We found that the R-
peptide cleavage defective mutants had significantly reduced infectivity. 
To investigate if R-peptide cleavage was needed for isomerization of the SU-TM 
disulfide, [35S]-Cys labelled mutants and wt virus were bound to target cells and then 
incubated for 0-30 min at 37 °C in the presence of M135. This locked the receptor 
triggered Envs in the IAS form. The alkylator was washed off and cells were lysed with 
NP-40, inducing isomerization in all unalkylated Envs. Analyses of immunoisolated 
Env proteins by non-reducing SDS-PAGE revealed reduced isomerization in all R-
peptide cleavage deficient mutants. Additionally, we analyzed the Env isomerization 
capacity of the mutants by Ca2+-depletion induced triggering in vitro. Incubation of wt 
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virus in buffers lacking Ca2+ removes an Env-stabilizing Ca2+, resulting in CXXC-thiol 
ionization and subsequent intersubunit disulfide isomerization (Wallin et al., 2004). 
Accordingly, the mutants and the wt virus were taken up in TN buffer (pH 8.0) without 
Ca2+ and incubated for 0-5 h at 37 °C. NEM was added during sample lysis to prevent 
lysis-induced isomerization and the viral proteins immunoisolated for SDS-PAGE at 
non-reducing conditions. We found that the cleavage defective mutants all had a 
reduced isomerization kinetics compared to wt virus. However, it should be noted that 
all mutants were still able to complete their isomerization reaction in 5 h. The R-peptide 
mutants, LV and LI contained varying, small amounts of processed TM i.e. Pr15E that 
was cleaved into p15E. When tracking the isomerization for the SU-Pr15E and SU-
p15E complexes of the mutants separately, it was apparent that it was the SU-Pr15E 
complexes that were inhibited in isomerization whereas the R-peptide cleaved SU-p15E 
complexes showed wt like isomerization. 
The results showed that the R-peptide interferred with SU-TM isomerization or any 
preceding steps, including receptor binding. We have not been able to find proof in the 
literature that R-peptide containing spikes actually bind to receptors. However, the 
receptor independent in vitro Env activation assay using Ca2+-depletion clearly showed 
that isomerization was hampered for R-peptide cleavage deficient mutants compared to 
wt virus. Thus, the inhibited isomerization for R-peptide cleavage deficient mutants is 
apparently not due to hindered receptor binding. The fact that the R-peptide cleavage 
deficient Env mutants were all able to completely isomerize in vitro during extended 
incubation, suggests that slow isomerization might not be the whole explanation for the 
almost complete fusion inhibition that was observed for the mutants. The R-peptide 
containing CT has previously been suggested to stabilize the Env oligomers through 
formation of a C-terminal coiled coil structure (Taylor and Sanders, 2003). This could 
prevent receptor induced changes in the Env that activate isomerization and also prevent 
downstream activation including TM backfolding. The R-peptide coiled-coil hypothesis 
has been supported by mutations in the R-peptide designed to destabilize a coiled-coil 
structure. Such mutants were shown to rescue fusion despite the retention of the R-
peptide. To find out the most critical steps that are inhibited in the fusion activation 
process of the R-peptide cleavage deficient mutants, a structural approach appears 
necessary. 
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4.3 COOPERATIVE CLEAVAGE OF THE R-PEPTIDE IN THE ENV TRIMER 
OF THE MOLONEY MURINE LEUKEMIA VIRUS FACILITATES ITS 
MATURATION FOR FUSION COMPETENCE (PAPER III). 
The MLV spike consists of Env trimers and we wanted to investigate how the R-peptide 
cleavage is regulated within the trimer. Our working model proposed that when one R-
peptide is cleaved this facilitates the cleavage of the other two. Thus a cooperative R-
peptide cleavage within the trimer is needed for efficient fusion activation. This 
hypothesis was tested by using Mo-MLV particles with partially cleaved R-peptide and 
an R-peptide specific antibody (αR) used for immunoprecipitation of intact SU-TM 
(Env) trimers, i.e. spikes. First we showed that αR did not cause trimer dissociation. For 
this purpose spikes from the R-peptide cleavage deficient mutant LR were solubilized 
and incubated together with different concentrations of αR. The spike and the spike-
antibody complexes were analyzed using BN-PAGE. This revealed the uncomplexed 
spike as SU-TM (Pr15E) trimers and the antibody-spike complexes as larger molecular 
associations. We concluded that the αR antibody does not dissociate the spike. To test 
the detection of Env heterotrimers, i.e. spikes with R-peptide cleaved (SU-p15E) and 
uncleaved Env (SU-Pr15E), we used a virus preparation cotransfected with wt and LR 
provirus DNA. We expected that wt and LR Env should form mixed trimers during 
biosynthesis in the ER and that the wt but not the LR TM (Pr15E) should be processed 
by the viral protease into p15E in the released particles. The wt/LR virus preparation 
was solubilized and immunoprecipitated using αR and analyzed by reducing SDS-
PAGE. This showed that the αR precipitated not only SU-Pr15E, as expected, but also a 
significant amount of SU-p15E complexes. Thus the wt/LR virus carried spikes 
consisting of SU-Pr15E / SU-p15E heterotrimers.  
To analyze the possibility of cooperative cleavage of Env R-peptides in the spikes of 
virus particles it was necessary to study a virus where the cleavage process was still 
incomplete. For this task we used the R-peptide cleavage deficient mutants L649I and 
L649V. These still supported about 10% and 20%, cleavage of Pr15E to p15E 
respectively. Thus, if heterotrimers were found it should be possible to coprecipitate 
SU-p15E with SU-Pr15E using αR. The immunoprecipitation assay did not reveal any 
coprecipitation of SU-p15E complexes from the lysed LV and LI mutants as found for 
the wt/LR virus. This suggested that R-peptide cleavage was a cooperative event within 
the trimer.  
Further we followed R-peptide cleavage in newly assembled wt virus. This was done 
using MOV-3 cells producing Mo-MLV. The cells were labelled with [35S]-Cys for 4 h 
and then virus particles were collected during 20 min. This newly released virus had 
about 40% of TM cleaved into p15E. By further incubating samples of the virus 
preparations at 37oC the amount of R-peptide cleavage could be increased. Thus we had 
the perfect samples to investigate if cleavage of the R-peptide generated SU-Pr15E / 
SU-p15E heterotrimers or SU-Pr15E and SU-p15E homotrimers. The samples were 
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immunoprecipitated with αR and no coprecipitation of SU-p15E with SU-Pr15E 
complexes was detected. This supported our model of cooperative R-peptide cleavage 
generating preferentially SU-p15E homotrimers rather than SU-Pr15E / SU-p15E 
heterotrimers. Next we wanted to investigate if the cooperative R-peptide cleavage was 
important for activation of the membrane fusion function of the spike. This was done by 
comparing two virus preparations with equal, about 50%, cleavage of the R-peptide, but 
where one contained heterotrimers and the other one homotrimeric spikes. The wt/LR 
virus represented the sample with heterotrimeric spikes and the sample with 
homotrimeric spikes was wt virus prepared in the presence of the virus protease 
inhibitor amprenavir. The drug preferentially inhibits the R-peptide cleavage over Gag 
cleavage. The virus dependent cell-cell fusion assay (fusion-from-without) showed that 
the wt/LR virus was significantly reduced in cell-cell fusion compared to the 
wt/amprenavir virus. Thus, the cooperative R-peptide cleavage facilitated the 
maturation of the viral spike for fusion competence. Our results about the cooperative 
cleavage of the R-peptides in one spike are consistent with previous data suggesting that 
the endodomains of SU-Pr15E trimers form a stable coiled-coil structure that suppresses 
the activation of the spike (Taylor and Sanders, 2003). In such a structure the cleavage 
of the R-peptide in one TM subunit is expected to disrupt the coiled-coil interaction, 
possibly resulting in the release of the uncleaved R-peptide tails of the other two 
subunits in a protease sensitive form. 
Surprisingly, when wt/LV and wt/LI virus were prepared by cotransfection of 293T 
cells with corresponding proviral DNAs, we found that they contained mostly R-peptide 
cleaved Env in their spikes and that SU-p15E, and the minor amount of SU-Pr15E 
complexes left, were forming homotrimers. This suggested that the mutated cleavage 
sites of the LV and LI SU-Pr15E complexes were cleaved in heterotrimers formed with 
the wt SU-Pr15E complexes. To make sure that this apparent cleavage rescue was not 
due to selective wt Env incorporation into virus an Influenza HA epitope was inserted 
into the PRR region of the LI and LR spike mutants using fusion-PCR. Previously, it 
was shown that the PRR tolerated insertion of the HA epitope and that this was exposed 
for antibody binding (Ou et al., 2006). The mutants created were referred to as LI-HA 
and LR-HA. Wt/LI-HA and wt/LR-HA viruses were then prepared by proviral DNA 
transfection of 293T cells and the viral spikes analyzed by αHA immunorecipitation. It 
was expected that upon cleavage-rescue in wt/LI-HA virus that αHA should precipitate 
relatively more SU-p15E complexes from wt/LI-HA virus than from wt/LR-HA virus, 
where no cleavage-rescue of mutated Env occurs. If LI-HA spikes were blocked in virus 
incorporation, no immunoprecipitable complexes should be formed in the wt/LI-HA 
virus. The result showed that SU-TM complexes were efficiently precipitated and that 
much more SU-p15E complexes were precipitated from lysed wt/LI-HA virus than from 
wt/LR-HA virus. This proved the rescue of the R-peptide cleavage of LI-HA in wt/LI-
HA heterotrimers and further supported the R-peptide cooperative cleavage mechanism. 
Accordingly, the cleavage of the CT in the wt SU-Pr15E complexes of wt/LI SU-Pr15E 
heterotrimers, possibly with their CTs as a coiled-coil, will present the CT of the mutant 
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The cooperativity found for the R-peptide cleavage reaction in the Env trimer helps 
explaining how symmetry and functionality can be maintained during this structural 
transition. It can be speculated that cooperative cleavage within the Env trimers could 
be a general event in virus maturation. For example, this could be the case during the 
furin cleavage of Env trimers into their separate SU and TM subunits. It is also possible 
that cooperative protease cleavage applies to the processing of Gag into its separate 
proteins, especially when this event is known to be executed quickly during the time 
limit of viral budding.    
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4.4 SINGLE-PARTICLE CRYOELECTRON MICROSCOPY ANALYSIS 
REVEALS THE HIV-1 SPIKE AS A TRIPOD STRUCTURE (PAPER IV). 
The 3D structure of the native HIV-1 spike has so far only been determined using cryo-
EM tomography with applied single particle technique. The resulting structures, from 
different groups, have been very dissimilar. These showed either a hollow spike head, 
which was connected to the viral membrane by a stem or a more compact spike with 
three feet. We wanted to use the well established methodology of single particle cryo-
EM and 3D reconstruction using the software EMAN to determine the structure of the 
native and CD4 receptor activated HIV-1 spike, i.e. the gp trimer. Our aim was to 
understand the initial conformational changes in the gp trimer during HIV-1 fusion 
activation. Due to gp120 shedding from virus particles incubated with soluble CD4 
(sCD4) we decided to work with a modified gp construct where the gp120 and gp41 
subunits were covalently linked by a disulfide. The modifications involved the 
introduction of a Cys into the C5 domain of gp120 and another Cys downstream of the 
disulfide loop region (CX5C Æ CX5CC) of gp41 (Binley et al., 2000). This gp, 
gp160SOS, has been shown to assemble into HIV-1 particles that upon CD4 receptor 
and coreceptor binding are trapped in an intermediate state of fusion activation. 
Treatment of the intermediate with a reducing agent (DTT) reduced the introduced 
disulfide bond and rescued membrane fusion (Abrahamyan et al., 2003; Binley et al., 
2003). Thus binding of sCD4 to gp160SOS should trigger the initial conformational 
changes without causing gp120 shedding. To increase the amount of Env incorporation 
into particles the cytoplasmic tail of TM was also deleted. The resulting gp was called 
gp160SOSΔCT (Binley et al., 2000). Virus particles containing gp160SOSΔCT were 
produced in 293T cells transfected with the DNAs encoding the modified gp and the 
proteins for particle formation. Virus particles were soloubilized with Triton X-100 and 
gp trimers were purified using sucrose gradient centrifugations. The gp trimers, or sCD4 
bound gp trimers, were then applied to holey carbon grids and immediately plunged 
frozen. EM pictures were taken using a JEOL2100F field emission transmission 
electron microscope with an accelerating voltage of 200 kV. Gp trimers were selected 
from the micrographs and used for reconstruction of their 3D structures.  
We found that the native HIV-1 gp trimer formed a hollow cage-like structure with 3-
fold interaction at the top and at the bottom. The gp protomeric unit could be divided 
into a common roof, a lobe and a leg on the side of the cage and a bottom part. The 
gp120 core atomic structure obtained in complex with the b12 Fab (Zhou et al., 2007) is 
believed to represent a close to native conformation and this structure fitted into our 
lobe density in a unique orientation. The CD4 binding site was located to the outer 
surface of the lobe and the silent face known to be extensively glycosylated was 
exposed to the surface. The stems of the deleted V1-V2 and V3 loops pointed into the 
roof suggesting these loops to occupy this region and to be responsible for the trimer 
interactions. We also fitted the atomic gp120 core structure with intact N- and C-
terminal ends obtained in complex with CD4 and 48d Fab (Pancera et al., 2010). The 
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30Å long N/C extension followed the density of the entire length of the leg in our 3D 
structure, validating its tripod nature.  
The hollow cage like structure was also clearly recognized in the CD4 bound HIV-1 
spike structure. However, three new protrusions appeared in the roof about 30Å from 
the center of the 3-fold axis. There was also a new protrusion in the upper part of the 
lobe. In general the CD4 binding caused a shift of density from the center of the roof to 
the periphery. In the bottom part of the liganded spike there was a shift of density from 
the peripheral bodies in the native structure to a central body instead. The CD4 bound 
atomic gp120 core structure with intact N- and C-terminals fitted perfectly into the lobe 
and leg densities. The atomic structure of the CD4 bound gp120 core containing an 
intact V3 loop also fitted into our density map of the CD4 bound spike. The V3 loop 
occupied the roof protrusion, the stem of the V1-V2 loops pointed into the lobe 
protrusion, whereas the core structure had almost the same fit in the lobe as in the native 
spike. This suggested that CD4 binding did not change the position of the gp120 core, 
but caused major conformational changes i.e. V3 was lifted up and V1-V2 displaced 
laterally. Similar displacement of the V1-V2 and V3 regions were previously described 
by Liu et al. in their cryo-EM tomography study, when they compared the structural 
transition between the native HIV spike and the CD4 activated spike stabilized by 17b 
Fab binding. However in their case, the structural transition was explained by a 
significant gp120 rotation. 
We believe that the V1-V2 loops cover the V3 loop and together they make the three 
fold interactions in the roof region in the native spike. This has been suggested before 
by epitope mapping and by the demonstration of a functional interplay between the V1-
V2 and V3 loops (Thali et al., 1993; Wyatt et al., 1995; Sullivan et al., 1998). It has also 
been shown that the V3 loop has conserved structural elements that could be important 
for these interactions (Jiang et al., 2010). In further support for our loop interaction 
model, there were recently two different cryo-EM tomography studies of SIV and HIV 
containing V1-V2 deletions. In general they confirmed a hollow spike head structure, 
but in both cases it was noted that the deletions resulted in loss of density at the three 
fold axis in the roof of the hollow spike (White et al., 2010; Hu et al., 2011). Our 
present results suggest that CD4 binding causes lateral displacement of the V1-V2 loops 
and the raising up of the V3 loops, apparently for coreceptor binding. This is supported 
by earlier biochemical studies (Wyatt et al., 1995; Sanders et al., 2000). 
The organization of gp41 in our spike structure remains elusive. The crystal structure of 
the post fusion gp41 does not fit into our unliganded or liganded spike density 
(Weissenhorn et al., 1997). This suggests that gp41 is not, as expected, arranged as a six 
helical bundle in either the native or the CD4 liganded spike. The C-terminal residue 
(A501) of the gp120 core structure containing the N/C-extension is in the 
gp160SOSΔCT construct substituted with the Cys that makes the covalent bond with 
the disulfide loop region of gp41. Thus, the latter part of gp41 should be located in the 
lower part of the leg in our spike density map. From here it is possible that the N-
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terminal region of the gp41 ectodomain, containing the N-helix and fusion peptide, 
ascends along the N/C extension until the inner domain β- sandwich. This is supported 
by the findings that mutations in the N/C extension and inner domain β-sandwich lead 
to dissociation of gp120 and gp41 (Finzi et al., 2010). The C-terminal part of gp41 
containing the C-helix and the MPER could together with the transmembrane region 
compose the peripheral body of the spike bottom.  
Our native spike structure is similar to that of Liu et al in the head region. Both contain 
a cavity with a roof and side lobes where the gp120 core structure fits. The 
dissimilarities between the two structures are mainly observed in the lower part of the 
molecule. Liu et al, reported a compact gp41 stalk, while we have an obvious tripod leg 
structure. However, the gp120 core structure containing the N/C extension pointed out 
of the density in the structure published by Liu et al. Thus the stem structure remains 
unvalidated. To explain this inconsistency it was suggested that the N/C extension was 
flexible and that the crystal structure might resemble an intermediate structure important 
for fusion (Pancera et al., 2010). However, the gp120 core structure with N/C extension 
fits perfectly into our spike density. The validity of our spike structure was further 
corroborated by several control reconstructions designed to exclude solubilization and 
cross-linking artifacts. In addition, the tripod structure we observed finds support from 
earlier cryo-ET studies of SIV and MLV (Forster et al., 2005; Zhu et al., 2006).  
There are several apparent similarities between the structure and function of the HIV-1 
and Mo-MLV spikes. The outer domain of the HIV-1 gp120 core with the V3 loop has 
similar functions as the MLV RBD. They are both heavily glycosylated, binds to the 
host cell receptor (mCAT-1 and the chemokine receptor) and are believed to transmit a 
signal to the rest of the fusion complex upon activation. The HIV-1 bridging sheet and 
the MLV PRR are also having functional similarities. They are both described as 
flexible regions transmitting a signal from the receptor binding domain to a region of 
the peripheral subunit interacting with the transmembrane subunit, i.e. the inner domain 
of the HIV-1 gp120 core and the Mo-MLV CTD, respectively. Further, the HIV-1 inner 
domain together with the N/C-extension is thought to interact with gp41. Upon 
activation this interaction is changed, releasing gp120 from gp41 and activating the 
metastable gp41. This function is similar to that of the MLV CTD. Here receptor 
binding transmits a signal, resulting in isomerization of the disulfide between SU and 
TM, leading to activation of TM for membrane fusion. Considering these functional 
similarities it is not surprising that the HIV-1 spike structure reported here has several 
similarities compared to the previously published MLV spike structure. They both share 
the hollow cage like feature with a compact roof, legs and lobes on the side of the cavity 
and a bottom part with peripheral bodies. The biggest difference between the two 
structures is the large middle protrusion in MLV. This protrusion might contain the 
disulfide isomerase region of MLV SU. Thus, not surprising, it is not present in the 
HIV-1 spike. In addition, the initial conformational changes observed upon fusion 
activation in the IAS form for MLV and in the CD4 bound spike for HIV-1 result in the 
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